Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis

Clinical trial NCT07587125 · RECRUITING

Trial details

NCT number: NCT07587125
Sponsor: Xijing Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS) Primary Progressive Multiple Sclerosis Multiple Sclerosis (MS) Secondary Progressive Refractory Multiple Sclerosis

Start date: 2026-05-08
Primary completion: 2027-11-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.